Global Point Of Care
Rapid Rule-in TB-HIV co-infection
Determine™ TB LAM Ag permite la detección inmediata de infección activa por tuberculosis (TB) en pacientes VIH positivos y proporciona resultados en tan solo unos minutos.
Esta prueba rápida detecta el antígeno LAM (lipoarabinomanano) en las muestras de orina, lo que le ayuda a realizar la prueba de detección de la TB para que actúe antes que los métodos tradicionales y le permita aplicar un tratamiento más temprano para su paciente.
Información del producto
Rendimiento
Especificidad1 4.0% | > 98% |
| Determine™ TB LAM Ag | Código |
|---|---|
| 25 pruebas de Determine™ TB LAM Ag | 7D2741 |
A Leader In Rapid Point-of-care Diagnostics.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
